The Epoch Times By
Pfizer Inc. announced on May 25 that it will provide all of its current and future patent-protected drugs and vaccines on a not-for-profit basis to 1.2 billion people in 45 lower-income countries.
The pharmaceutical and biotechnology company said in a press release that the plan is part of “An Accord for a Healthier World,” launched with the aim to address health inequities between many lower-income countries and the rest of the world.
The 23 drugs and vaccines to be made available to the lower-income countries help treat and prevent a range of infectious diseases including COVID-19, pneumonia, and meningitis. They also help to treat certain cancers, including types of leukemia, breast cancer, and advanced kidney cancer, and help to manage inflammatory and rare diseases.
